SuperworthSilexion Therapeutics market cap SLXN
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $1M
- Highest close in our data
- $14.3M
- Aug 2024
Silexion Therapeutics is worth $1M at the close on Oct 23, 2026, at $0.19 a share.
That is down 58% over the last year.
Its highest close in our data was $14.3M in Aug 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1M | $783.5K | $7.1M | −85% |
| 2025 | $7.2M | $720K | $9.4M | +214% |
| 2024 | $2.3M | $2.1M | $14.3M | n/a |
Against its peers
Companies in Biotechnology nearest Silexion Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| SLXNSilexion Therapeutics | $1M |
| CRISCuris | $807.4K |
| CLDICalidi Biotherapeutics | $1.6M |
| VIVSVivoSim Labs, INC. | $2.2M |
| PMCBPharmaCyte Biotech | $3.8M |
| LIMNLiminatus Pharma | $3.9M |
| AIMAIM ImmunoTech | $4.8M |
| CELZCreative Medical Technology | $4.9M |
| SNTISenti Biosciences | $5.9M |
| INABIN8BIO | $10.4M |
| INTSIntensity Therapeutics | $10.6M |
| Peer median | $4.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Silexion Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.